-Welcome remarks. Dr. Askar Yedilbayev, Regional TB and DR-TB Advisor, Joint Infectious Diseases Unit, WHO Regional Office for Europe, Denmark
-Updated WHO consolidated guidelines on DR-TB treatment 2025. Dr. Fuad Mirzayev, WHO Headquarters, Geneva
-BEAT-TB trial: Insights on the effectiveness and safety of new 6-month regimens for DR-TB. Dr. Francesca Conradie, WHO Headquarters, Geneva
-Rebranding of VMC to European Virtual Medical Consilium on TB: New name, same support. Dr. Elmira Gurbanova, Coordinator of the European Virtual Medical Consilium on TB